Investors

OvaScience is a life sciences company focused on the discovery, development and commercialization of new treatments for infertility.

OVAS (Common Stock)
Price & Exchange
$43.73
NASDAQ
Change (%)
 Stock is Up 3.22 (7.95%)
Volume
238,164
12/24/14      4:00 p.m. ET

Minimum 20 minute delay
Refresh quote

Investor Overview

Recent News

More »
DateTitle 
12/17/14OvaScience Advances All Three Fertility Treatment Options
- AUGMENT Treatment Available in Four International Regions - - OvaPrime Treatment to be Introduced into Select International IVF Clinics by the End of 2015 - - OvaTure Treatment, a Potential Hormone-Free Fertility Option, Progresses into Development - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 17, 2014-- OvaScienceSM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization... 
Printer Friendly Version
12/12/14OvaScience to Host Investor Day
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 12, 2014-- OvaScienceSM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that the Company is hosting an Investor Day on Wednesday, December 17, 2014 at the Benjamin Hotel in New York from 8:00 a.m. to approximately 11:30 a.m. ET. The event will feature presentations by guest speakers and Company management on the ... 
Printer Friendly Version
12/11/14OvaScience Strengthens Management Team to Support Expanding Global Operations
- Promotes Arthur Tzianabos, Ph.D., to President; Appoints New Head of Commercial - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 11, 2014-- OvaScienceSM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today key changes to the leadership team that will support OvaScience’s expanding global commercial operations. Arthur Tzianabos, Ph.D., has been... 
Printer Friendly Version
12/04/14OvaScience to Present at the Oppenheimer Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 4, 2014-- OvaScienceSM (NASDAQ:OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Company management will present at the Oppenheimer 25th Annual Healthcare Conference on Thursday, December 11, 2014 at 2:10 pm ET at the Crowne Plaza Times Square hotel in New York. A live audio webcast of the presentation c... 
Printer Friendly Version

Upcoming Events

More »
There are currently no events scheduled.
Powered by Thomson Reuters
Data Provided by Thomson Reuters
Minimum 20 minutes delayed